You don't need to be signed in to read BMJ Group Blogs, but you can register here to receive updates about other BMJ Group products and services via our Group site.

SLE

12 Dec, 07 | by Ian Wacogne

In a series of 19 patients with very severe SLE the use of rituximab, an agent which depletes B cells, was helpful in controlling symptoms. Here.

Posted in Rheumatology.
Respond
Print page

Leave a Reply

You can follow any responses to this entry through the RSS 2.0 feed.
« Hearing screening
Down Syndrome »
ADC Precis blog homepage

ADC Online

A peer review journal for health professionals and researchers covering conception to adolescence. Visit site

BMJ Clinical Evidence updates